Sanford Guide Introduces New Mobile App for Treatment of Infectious Diseases

SPERRYVILLE, Virginia, July 12, 2011 /PRNewswire/ --

Frequent Updates Stay Current with New Emerging Infections, Drug-Resistant 'Superbugs'

The Sanford Guide, recognized as the essential reference for infectious disease treatment, announced the release of its first mobile app for the iPhone, iPod touch and iPad.  The Sanford Guide App, available on Apple's App Store for $29.99, contains the comprehensive guidelines and recommendations featured in the well-known pocket-size guides used by health care professionals in treatment decision making for over 40 years.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/sanfordguide/50808/

(Photo:  http://photos.prnewswire.com/prnh/20110712/MM31904 )

The new mobile Sanford Guide provides convenient access to critical information on treatment of infectious diseases, for use by health care professionals for timely, effective treatment at the point of care - whether at an urban ICU in Germany, a crowded HIV ward in Kampala, Uganda, a medical relief tent in Sichuan, China or an overworked primary care clinic in Iowa.  

Advantages include easy navigation and search tools, extensive internal links, and source references throughout.  Regular updates will reflect new drugs, shifting resistance patterns, the emergence of new diseases, and the changing availability and efficacy of anti-infective therapies.  

The editors of the Sanford Guide are among the world's foremost infectious disease experts.  Each member of the Editorial Board is associated with a leading medical school and major teaching hospital. The Board is geographically diverse and the collective expertise and experience of the editors covers the complex field of infectious diseases.

"This is a huge leap forward for the Sanford Guide, to take advantage of current, state-of-the art technology to improve how we bring the most comprehensive infectious disease treatment information to the field," said Jeb Sanford, managing editor.  "The ability to deliver critical information at the point of care makes the Sanford Guide App an essential tool for all health care professionals who may deal with infectious diseases."

The world faces dangers from increased antimicrobial resistance to long-established drug treatments for diseases like pneumonia and tuberculosis while at the same time having to cope with new emerging infections like highly resistant staph, H1N1 flu and new strains of E. coli bacteria. The challenge remains how best to deliver information relevant to treatment conveniently and quickly at the point of care.  Doctors and other health care providers have come to rely on the Sanford Guide, which provides the comprehensive content, extensive source references, user-friendly format and portability that make it the "gold standard" reference in its field.  

The Sanford Guide delivers convenient, comprehensive recommendations for treatment and prevention of bacterial, fungal, viral, retroviral, parasitic and mycobacterial infections.  It provides recommendations for surgical prophylaxis, and relevant drug information covering pharmacology, adverse effects, drug-drug interactions and dose adjustments, all supported by editor commentary and detailed references.

Antimicrobial Therapy, Inc., publisher of the Sanford Guides, has been owned and operated by the Sanford family since 1969.  More information is available at http://www.sanfordguide.com.

CONTACT:
Peter Whalen, Peritus Public Relations
+1-502-292-4045
pwhalen@perituspr.com

SOURCE Sanford Guide